Abstract
Among acquired stem cell disorders aethiopathological links have been established between hypoplastic MDS, aplastic anemia (AA), paroxysmal nocturnal hemoglobinuria (PNH) and T-cell large granular lymphocytic leukemia (T-LGL) (see Fig. 10.1). All these entities are bone marrow failure disorders1 in which oligoclonal T-cell-mediated immune responses are without doubt pathophysiologically relevant. These overlap syndromes seem to form some kind of disease-continuum, whereby each entity can occur on its own, or arise in the background of any of the other above-mentioned diseases. As an example, PNH may follow, or precede MDS, and MDS-clones as well as PNH-clones are often detectable in patients with aplastic anemia. It may well be that T-LGL represents one extreme end of this spectrum, characterized by maximal clonal/oligoclonal T-cell proliferation, as LGL-like immunodominant cytotoxic lymphocyte (CTL) clonotypes are found within the whole spectrum of this continuum of overlap syndromes [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nishimura J, Kanakura Y, Ware RE et al. (2004) Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore) 83: 193–207
Maciejewski JP, O’Keefe C, Gondek L, Tiu R (2007) Immunemediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobiol 45: 5–14
Risitano AM, Kook H, Zeng W, Chen G, Young NS, Maciejewski JP (2002) Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood 100: 178–183
Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 364: 355–364
Wlodarski MW, Gondek LP, Nearman ZP et al. (2006) Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome. Blood 108: 2632–2641
Plasilova M, Risitano A, Maciejewski JP (2003) Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases. Hematology 8: 173–181
Epling-Burnette PK, Painter JS, Rollison DE et al. (2007) Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome. Leukemia 21: 659–667
Sloand EM, Mainwaring L, Fuhrer M et al. (2005) Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 106: 841–851
Parker CJ (2007) The pathophysiology of paroxysmal nocturnal hemoglobinuria. Exp Hematol 35: 523–533
Maciejewski JP, Follmann D, Nakamura R et al. (2001) Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood 98: 3513–3519
Iwanaga M, Furukawa K, Amenomori T et al. (1998) Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Br J Haematol 102: 465–474
Dunn DE, Tanawattanacharoen P, Boccuni P et al. (1999) Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 131: 401–408
Young NS, Scheinberg P, Calado RT (2008) Aplastic anemia. Curr Opin Hematol 15: 162–168
Dubey S, Shukla P, Nityanand S (2005) Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol 84: 572–577
Gidvani V, Ramkissoon S, Sloand EM, Young NS (2007) Cytokine gene polymorphisms in acquired bone marrow failure. Am J Hematol 82: 721–724
Scopes J, Bagnara M, Gordon-Smith EC, Ball SE, Gibson FM (1994) Haemopoietic progenitor cells are reduced in aplastic anaemia. Br J Haematol 86: 427–430
Scopes J, Daly S, Atkinson R, Ball SE, Gordon-Smith EC, Gibson FM (1996) Aplastic anemia: evidence for dysfunctional bone marrow progenitor cells and the corrective effect of granulocyte colony-stimulating factor in vitro. Blood 87: 3179–3185
Killick SB, Cox CV, Marsh JC, Gordon-Smith EC, Gibson FM (2000) Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol 111: 1164–1169
Ismail M, Gibson FM, Gordon-Smith EC, Rutherford TR (2001) Bcl-2 and Bcl-x expression in the CD34+ cells of aplastic anaemia patients: relationship with increased apoptosis and upregulation of Fas antigen. Br J Haematol 113: 706–712
Kakagianni T, Giannakoulas NC, Thanopoulou E et al. (2006) A probable role for trail-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients. Leuk Res 30: 713–721
Greil R, Anether G, Johrer K, Tinhofer I (2003) Tuning the rheostat of the myelopoietic system via Fas and TRAIL. Crit Rev Immunol 23: 301–322
Mukhina GL, Buckley JT, Barber JP, Jones RJ, Brodsky RA (2001) Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol 115: 476–482
Wang H, Chuhjo T, Yamazaki H et al. (2001) Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis. Eur J Haematol 66: 200–205
Mortazavi Y, Merk B, McIntosh J, Marsh JC, Schrezenmeier H, Rutherford TR (2003) The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot. Blood 101: 2833–2841
Lewis SM, Dacie JV (1967) The aplastic anaemia—paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol 13: 236–251
Araten DJ, Bessler M, McKenzie S et al. (2002) Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia 16: 2243–2248
Wanachiwanawin W, Siripanyaphinyo U, Piyawattanasakul N, Kinoshita T (2006) A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia. Eur J Haematol 76: 502–509
Kinoshita T, Inoue N (2002) Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Int J Hematol 75: 117–122
Kanwar VS, Wang WC, Winer-Muram HT, Kauffman WM, Gronemeyer SA, Head DR (1995) Magnetic resonance imaging for evaluation of childhood aplastic anemia. J Pediatr Hematol Oncol 17: 284–289
Kusumoto S, Jinnai I, Matsuda A et al. (1997) Bone marrow patterns in patients with aplastic anaemia and myelodysplastic syndrome: observations with magnetic resonance imaging. Eur J Haematol 59: 155–161
Gupta G, Robertson P, Szer J (2007) Focal lesions on magnetic resonance imaging in aplastic anaemia: multiple metastases or haemopoietic marrow. Australas Radiol 51 Spec No.: B110–B114
Masumoto A, Yonekura S, Ogawa Y et al. (1993) Changes of bone marrow MRI pattern in aplastic anemia before and after bone marrow transplantation. Rinsho Ketsueki 34: 1494–1496
Sessa M, Della SM, Bianchi D et al. (1995) Magnetic resonance aspects of the bone marrow in aplastic anemia at the onset and in the follow-up after transplant. Radiol Med (Torino) 89: 130–135
Yagisawa M, Iki S, Mitani K, Ohbayashi Y, Sato H, Urabe A (1992) Changes in bone marrow MRI patterns in aplastic anemia before and after successful treatment with ATG. Rinsho Ketsueki 33: 811–816
Negendank W, Weissman D, Bey TM et al. (1991) Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disorders. Blood 78: 2872–2879
Steiner RM, Mitchell DG, Rao VM et al. (1990) Magnetic resonance imaging of bone marrow: diagnostic value in diffuse hematologic disorders. Magn Reson Q 6: 17–34
Porter BA, Shields AF, Olson DO (1986) Magnetic resonance imaging of bone marrow disorders. Radiol Clin North Am 24: 269–289
Olson DO, Shields AF, Scheurich CJ, Porter BA, Moss AA (1986) Magnetic resonance imaging of the bone marrow in patients with leukemia, aplastic anemia, and lymphoma. Invest Radiol 21: 540–546
Socie G, Henry-Amar M, Bacigalupo A et al. (1993) Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 329: 1152–1157
Socie G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A (2000) Late clonal diseases of treated aplastic anemia. Semin Hematol 37: 91–101
Kojima S, Ohara A, Tsuchida M et al. (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 100: 786–790
Socie G, Mary JY, Schrezenmeier H et al. (2007) Granulocytestimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood 109: 2794–2796
Ohara A, Kojima S, Hamajima N et al. (1997) Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 90: 1009–1013
Locasciulli A, Arcese W, Locatelli F, Di Bona E, Bacigalupo A (2001) Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet 357: 43–44
Kwong YL, Wong KF (1998) Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol 51: 672–675
Loughran TP Jr, Kidd P, Poiesz BJ (1994) Familial occurrence of LGL leukaemia. Br J Haematol 87: 199–201
Loughran TP Jr (1993) Clonal diseases of large granular lymphocytes. Blood 82: 1–14
Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL (1994) Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 84: 1620–1627
Saunthararajah Y, Molldrem JL, Rivera M et al. (2001) Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 112: 195–200
Go RS, Lust JA, Phyliky RL (2003) Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Semin Hematol 40, 196–200
Karadimitris A, Li K, Notaro R et al. (2001) Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. Br J Haematol 115: 1010–1014
Loughran TP Jr, Clark EA, Price TH, Hammond WP (1986) Adult-onset cyclic neutropenia is associated with increased large granular lymphocytes. Blood 68: 1082–1087
Loughran TP Jr, Hammond WP (1986) Adult-onset cyclic neutropenia is a benign neoplasm associated with clonal proliferation of large granular lymphocytes. J Exp Med 164: 2089–2094
Abkowitz JL, Kadin ME, Powell JS, Adamson JW (1986) Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol 63: 59–67
Motoji T, Yamada O, Takahashi M, Oshimi K, Mizoguchi H (1992) Granular lymphocyte leukemia with pure red cell aplasia: usefulness of gene analysis in assessing therapeutic effect. Am J Hematol 39: 212–219
Mori S, Suzushima H, Nishikawa K et al. (1995) Smoldering gamma delta T-cell granular lymphocytic leukemia associated with pure red cell aplasia. Acta Haematol 94: 32–35
Hirayama Y, Nagai T, Ohta H et al. (1997) A case of pure red cell aplasia accompanied with granular lymphocytic leukemia the tumor cells of which suppressed colony formation of BFU-E, and which was successfully treated by cyclophosphamide and cyclosporin A. Rinsho Ketsueki 38: 1206–1211
Yamada O, Motoji T, Mizoguchi H (1999) Selective effect of cyclosporine monotherapy for pure red cell aplasia not associated with granular lymphocyte-proliferative disorders. Br J Haematol 106: 371–376
Fujishima N, Sawada KI, Hirokawa M et al. (2008) Longterm responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 93(10): 1555–1559
Lacy MQ, Kurtin PJ, Tefferi A (1996) Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 87: 3000–3006
Masuda M, Teramura M, Matsuda A et al. (2005) ClonalT cells of pure red-cell aplasia. Am J Hematol 79: 332–333
Matrai Z, Lelkes G, Milosevits J, Paldine HP, Pecze K (1997) T-cell large granular lymphocytic leukemia associated with pure red cell aplasia, successfully treated with cyclophosphamide. Orv Hetil 138: 2075–2080
Palomera BL, Garcia DI (1990) Pure red cell aplasia and neutropenia associated with chronic monoclonal T-lymphocytosis. Med Clin (Barc) 94: 262–265
Ru X, Liebman HA (2003) Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol 123: 278–281
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Pleyer, L., Neureiter, D., Greil, R. (2010). Clonal Bone Marrow Failure Overlap Syndromes. In: Greil, R., Pleyer, L., Faber, V., Neureiter, D. (eds) Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Springer, Vienna. https://doi.org/10.1007/978-3-211-79892-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-211-79892-8_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-79891-1
Online ISBN: 978-3-211-79892-8
eBook Packages: MedicineMedicine (R0)